Literature DB >> 22858390

Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study.

Enrico Romagnoli1, Giuseppe Biondi-Zoccai, Alessandro Sciahbasi, Luigi Politi, Stefano Rigattieri, Gianluca Pendenza, Francesco Summaria, Roberto Patrizi, Ambra Borghi, Cristian Di Russo, Claudio Moretti, Pierfrancesco Agostoni, Paolo Loschiavo, Ernesto Lioy, Imad Sheiban, Giuseppe Sangiorgi.   

Abstract

OBJECTIVES: The purpose of this study was to assess whether transradial access for ST-segment elevation acute coronary syndrome undergoing early invasive treatment is associated with better outcome compared with conventional transfemoral access.
BACKGROUND: In patients with acute coronary syndrome, bleeding is a significant predictor of worse outcome. Access site complications represent a significant source of bleeding for those patients undergoing revascularization, especially when femoral access is used.
METHODS: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) was a multicenter, randomized, parallel-group study. Between January 2009 and July 2011, 1,001 acute ST-segment elevation acute coronary syndrome patients undergoing primary/rescue percutaneous coronary intervention were randomized to the radial (500) or femoral (501) approach at 4 high-volume centers. The primary endpoint was the 30-day rate of net adverse clinical events (NACEs), defined as a composite of cardiac death, stroke, myocardial infarction, target lesion revascularization, and bleeding). Individual components of NACEs and length of hospital stay were secondary endpoints.
RESULTS: The primary endpoint of 30-day NACEs occurred in 68 patients (13.6%) in the radial arm and 105 patients (21.0%) in the femoral arm (p = 0.003). In particular, compared with femoral, radial access was associated with significantly lower rates of cardiac mortality (5.2% vs. 9.2%, p = 0.020), bleeding (7.8% vs. 12.2%, p = 0.026), and shorter hospital stay (5 days first to third quartile range, 4 to 7 days] vs. 6 [range, 5 to 8 days]; p = 0.03).
CONCLUSIONS: Radial access in patients with ST-segment elevation acute coronary syndrome is associated with significant clinical benefits, in terms of both lower morbidity and cardiac mortality. Thus, it should become the recommended approach in these patients, provided adequate operator and center expertise is present. (Radial Versus Femoral Investigation in ST Elevation Acute Coronary Syndrome [RIFLE-STEACS]; NCT01420614).
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858390     DOI: 10.1016/j.jacc.2012.06.017

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  197 in total

Review 1.  Optimization of Antiplatelet Therapy in STEMI.

Authors:  Abhishek Sinha; Kush Agrawal; Rahul Sakhuja
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 2.  Ubiquitin-free routes into the proteasome.

Authors:  M A Hoyt; P Coffino
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

Review 3.  Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.

Authors:  Sandeep Nathan; Sunil V Rao
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 4.  [Intra-aortic balloon pump (IABP) counterpulsation. Do we still need it and if so when?].

Authors:  M Russ
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-04       Impact factor: 0.840

5.  The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Authors:  Emily Perdoncin; Milan Seth; Simon Dixon; Louis Cannon; Akshay Khandelwal; Arthur Riba; Shukri David; David Wohns; Hitinder Gurm
Journal:  Eur Heart J       Date:  2015-09-15       Impact factor: 29.983

6.  Radial Interventions: Present and Future Indications.

Authors:  Konstantinos V Voudris; Panagiota Georgiadou; Konstantinos Charitakis; Konstantinos Marmagkiolis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

7.  Comparison of transradial and transfemoral artery approach for percutaneous coronary angiography and angioplasty: a retrospective seven-year experience from a north Indian center.

Authors:  Satyendra Tewari; Naveen Sharma; Aditya Kapoor; Sanjeev Kumar Syal; Sudeep Kumar; Naveen Garg; Pravin K Goel
Journal:  Indian Heart J       Date:  2013-07-12

8.  Transradial left ventricular endomyocardial biopsy: assessment of safety and efficacy.

Authors:  Tim G Schäufele; Raphael Spittler; Artemisia Karagianni; Peter Ong; Karin Klingel; Reinhard Kandolf; Heiko Mahrholdt; Udo Sechtem
Journal:  Clin Res Cardiol       Date:  2015-04-02       Impact factor: 5.460

9.  Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia.

Authors:  Matthew W Sherwood; Sunil V Rao
Journal:  Nat Rev Cardiol       Date:  2013-02-05       Impact factor: 32.419

10.  Risk factors of failed transradial approach for percutaneous coronary interventions in Chaoshan Chinese: a locally retrospective analysis.

Authors:  Jing Hu; Xiangna Cai; Xin Wang; Lan Chen; Duanmin Xu; Jilin Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.